Loading stock data...

Amerise Biosciences Ltd.

BSE: AMERISE

BSE
0.88 0.00 (0.00%)

Prev Close

0.88

Open Price

0.88

Volume

97,863

Today Low / High

0.86 / 0.91

52 WK Low / High

0.83 / 1.33

Range

1 - 1

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 0.88, reflecting a change of 0 (0%). The expected target range on the BSE is 1 - 1. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.

24 Apr 0.88 0.00%
23 Apr 0.86 2.33%
22 Apr 0.87 -2.30%
21 Apr 0.89 -1.12%
17 Apr 0.90 -3.33%
16 Apr 0.90 -1.11%
15 Apr 0.91 -3.30%
11 Apr 0.91 0.00%
09 Apr 0.89 0.00%
08 Apr 0.89 4.49%
07 Apr 0.94 -7.45%
04 Apr 0.91 2.20%
03 Apr 0.88 5.68%
02 Apr 0.94 -4.26%
01 Apr 0.91 3.30%
28 Mar 0.89 2.25%
27 Mar 0.89 -2.25%

Amerise Biosciences Ltd. Graph

Amerise Biosciences Ltd. Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Amerise Biosciences Ltd. T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 0.88, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 0.88 0.89 0.80 - 0.98
0.90 0.72 - 1.08
0.91 0.63 - 1.18
Bearish Scenario 0.88 0.87 0.78 - 0.96
0.86 0.69 - 1.03
0.85 0.60 - 1.11

Overview of Amerise Biosciences Ltd.

ISIN

INE673C01020

Industry

Financial - Conglomerates

Vol.Avg

130,979

Market Cap

58,140,720

Last Dividend

0

Official Website

Visit Website

IPO Date

DCF Diff

0.86

DCF

0

Financial Ratios Every Investor Needs

Stock Rating Details for AMERISE

Metric Value Recommendation
Overall Rating C- Strong Sell
DCF Score 3 Neutral
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2024-03-31 0.04 Cr 0.07 Cr -0.03 Cr -0.9415 0.00 Cr 0.00 Cr -0.15 Cr -0.15 Cr -0.02 -0.15 Cr -4.0696
2023-03-31 0.00 Cr 0.00 Cr 0.00 Cr 0.0000 0.00 Cr 0.00 Cr -0.13 Cr -0.12 Cr -0.02 -0.13 Cr 0.0000
2022-03-31 9.01 Cr 8.97 Cr 0.04 Cr 0.0045 0.00 Cr 0.00 Cr -0.02 Cr 0.55 Cr 0.08 0.55 Cr 0.0610
2021-03-31 0.00 Cr 0.00 Cr 0.00 Cr 0.0000 0.00 Cr 0.00 Cr -0.17 Cr -0.34 Cr -0.05 -0.34 Cr 0.0000
2020-03-31 0.00 Cr 0.00 Cr 0.00 Cr 0.0000 0.00 Cr 0.00 Cr -0.15 Cr -0.15 Cr -0.02 -0.15 Cr 0.0000

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2024-03-31 0.02 Cr 5.39 Cr 0.02 Cr 5.3741 Cr 0.00 Cr -0.02 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 2.26 Cr 0.0155 Cr
2023-03-31 0.01 Cr 5.65 Cr 0.13 Cr 5.4389 Cr 0.09 Cr 0.08 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 5.63 Cr 0.0369 Cr
2022-03-31 0.01 Cr 11.99 Cr 6.35 Cr 5.6392 Cr 0.08 Cr 0.07 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 5.76 Cr 6.2666 Cr
2021-03-31 0.02 Cr 5.63 Cr 0.54 Cr 5.0900 Cr 0.00 Cr -0.02 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 5.61 Cr 0.5379 Cr
2020-03-31 0.03 Cr 6.02 Cr 0.60 Cr 5.4271 Cr 0.00 Cr -0.03 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 6.00 Cr 0.5952 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2024-03-31 -0.1694 Cr 0.2669 Cr -0.0900 Cr -0.1694 Cr 0.0075 Cr 0.0211 Cr 0.1693 Cr -0.1461 Cr -0.0900 Cr 0.0000 Cr 0.0000 Cr
2023-03-31 -0.1321 Cr 0.1255 Cr 0.0073 Cr -0.1321 Cr 0.0006 Cr 0.0136 Cr 0.0000 Cr -0.1189 Cr 0.0000 Cr 0.0000 Cr 0.0000 Cr
2022-03-31 0.0614 Cr -0.1505 Cr 0.0827 Cr 0.0614 Cr -0.0064 Cr 0.0130 Cr 0.0000 Cr 0.5492 Cr 0.0000 Cr 0.0000 Cr 0.0000 Cr
2021-03-31 -0.3945 Cr 0.3887 Cr 0.0000 Cr -0.3945 Cr -0.0058 Cr 0.0193 Cr 0.0000 Cr -0.3371 Cr 0.0000 Cr 0.0000 Cr 0.0000 Cr
2020-03-31 4.8937 Cr -4.8870 Cr 0.0000 Cr 4.8937 Cr 0.0067 Cr 0.0251 Cr 0.0000 Cr -0.1491 Cr 0.0000 Cr 0.0000 Cr 0.0000 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2024-12-31 0.00 Cr 0.01 Cr -0.01 Cr 0.0000 -0.02 Cr -0.02 Cr 0.00 -0.02 Cr 0.0000
2024-09-30 0.00 Cr 0.01 Cr -0.01 Cr 0.0000 -0.03 Cr -0.03 Cr -0.01 -0.03 Cr 0.0000
2024-06-30 0.00 Cr 0.00 Cr 0.00 Cr 0.0000 -0.05 Cr -0.05 Cr -0.01 -0.05 Cr 0.0000
2024-03-31 0.04 Cr 0.02 Cr 0.02 Cr 0.5475 0.02 Cr 0.02 Cr 0.00 0.02 Cr 0.5475
2023-12-31 0.00 Cr 0.00 Cr 0.00 Cr 0.0000 -0.06 Cr -0.06 Cr -0.01 -0.06 Cr 0.0000

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2024-09-30 0.01 Cr 0.00 Cr 0.02 Cr 0.00 Cr 0.00 Cr 0.02 Cr 0.00 Cr 5.33 Cr 0.04 Cr
2024-03-31 0.02 Cr 0.00 Cr 0.02 Cr 0.00 Cr 0.00 Cr 0.02 Cr 0.00 Cr 5.39 Cr 0.02 Cr
2023-12-31 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-09-30 0.04 Cr 0.00 Cr 0.04 Cr 0.00 Cr 0.00 Cr 0.04 Cr 0.00 Cr 5.56 Cr 0.14 Cr
2023-06-30 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2023-12-31 -0.06 Cr -0.06 Cr 0.00 Cr 0.00 Cr -0.10 Cr -0.06 Cr 0.04 Cr 0.00 Cr -0.06 Cr
2023-09-30 -0.04 Cr -0.04 Cr 0.00 Cr 0.00 Cr -0.04 Cr 0.04 Cr 0.07 Cr 0.00 Cr -0.04 Cr
2023-06-30 -0.07 Cr -0.07 Cr 0.00 Cr 0.00 Cr -0.08 Cr -0.07 Cr 0.01 Cr 0.00 Cr -0.07 Cr
2023-03-31 -0.02 Cr -0.02 Cr 0.00 Cr 0.00 Cr -0.02 Cr 0.01 Cr 0.03 Cr 0.00 Cr -0.02 Cr
2022-12-31 -0.05 Cr -0.05 Cr 0.00 Cr 0.00 Cr -0.07 Cr -0.05 Cr 0.02 Cr 0.00 Cr -0.05 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Financial - Conglomerates

Company Name Symbol Price Market Cap Volume
Bajaj Finserv Ltd. BAJAJFINSV ₹2,105.00 ₹3,358,105,531,700.00 ₹1,464,767.00
Aditya Birla Capital Limited ABCAPITAL ₹203.10 ₹529,483,731,000.00 ₹3,593,055.00
India Grid Trust INDIGRID-IV ₹147.79 ₹123,339,326,820.00 ₹192,561.00

Key Executives

Chief Financial Officer, Chairman & Whole Time Director
Mr. Dineshkumar Tribhovanbhai Rathod

Gender: male

Year Born: 1977

Company Secretary
Ms. Minal Vinodkumar Lakhlani

Gender: female

Year Born:

FAQs about Amerise Biosciences Ltd.

Who is the CEO of the company?

The CEO is Mr. Dineshkumar Tribhovanbhai Rathod.

What is the current market price of the stock?

The current price is ₹0.88.

What is the 52-week price range?

The range is ₹0.83-1.33.

What is the market capitalization of the company?

The market capitalization is ₹5.81 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is -73.88.

Which sector does the company belong to?

The company operates in the Financial Services sector.

What does the company do?

Overview of Amerise Biosciences Ltd. (ISIN: INE673C01020) is a leading Financial - Conglomerates in India. With a market capitalization of ₹5.81 crores and an average daily volume of 130,979 shares, it operates in the Financial - Conglomerates. The company last declared a dividend of ₹0.

Welcome to the Investing and Trading Information platform: InvesTrack.in

Note: This platform is for educational and informational purposes only. Do not consider anything as financial advice.

QUICK LINKS

Home
About us
Contact us
Privacy Policy
Disclaimer
Sitemap
Investing
Trading
Top Brokers
Tools
Live Analysis

STAY CONNECTED

Follow Us On Social Media
Get Latest Update On Social Media
Facebook Instagram Twitter

General Disclaimer: InvesTrack is an educational platform and not any type of investment advisory platform. Our Blog and videos are based on countless hours of research and experience, which you can use as a guide for your research purposes. None of our content should be considered a piece of investment advice. Earning Disclosure: InvesTrack is a community supported platform. We may earn a commission when you make a purchase through one of our links at no extra cost to you. Note: We are not SEBI Registered Advisors. This website is purely for training and educational purposes. We shall not be responsible for your profit or loss.

© Copyright 2024 - 2025 | InvesTrack